Vaccines for Pandemic Influenza pp 177-195

Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 333)

Attenuated Influenza Virus Vaccines with Modified NS1 Proteins

Abstract

The development of reverse genetics techniques allowing the rescue of influenza virus from plasmid DNA has opened up the possibility of inserting mutations into the genome of this virus for the generation of novel live attenuated influenza virus vaccines. Modifications introduced into the viral NS1 gene via reverse genetics have resulted in attenuated influenza viruses with promising vaccine potential. One of the main functions of the NS1 protein of influenza virus is the inhibition of the innate host type I interferon-mediated antiviral response. Upon viral infection, influenza viruses with modified NS1 genes induce a robust local type I interferon response that limits their replication, resulting in disease attenuation in different animal models. Nevertheless, these viruses can be grown to high titers in cell- and egg-based substrates with deficiencies in the type I IFN system. Intranasal inoculation of mice, pigs, horses, and macaques with NS1-modified influenza virus strains induced robust humoral and cellular immune responses, and generated immune protection against challenge with wild-type virus. This protective response was not limited to homologous strains of influenza viruses, as reduced replication of heterologous strains was also demonstrated in animals vaccinated with NS1-modified viruses, indicating the induction of a broad cross-neutralizing response by these vaccine candidates. The immunogenicity of NS1-modified viruses correlated with enhanced activation of antigen-presenting cells. While further studies on their safety and efficacy are still needed, the results obtained so far indicate that NS1-modified viruses could represent a new generation of improved influenza virus vaccines, and they suggest that modifying viral interferon antagonists in other virus families is a promising strategy for the generation of live attenuated virus vaccines.

References

  1. Aragón T, de La Luna S, Novoa I, Carrasco L, Ortín J, Nieto A (2000) Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20:6259–6268CrossRefPubMedGoogle Scholar
  2. Baskin CR, Bielefeldt-Ohmann H, García-Sastre A, Tumpey TM, Van Hoeven N, Carter VS, Thomas MJ, Proll S, Solorzano A, Billharz R, Fornek JL, Thomas S, Chen CH, Clark EA, Murali-Krishna K, Katze MG (2007) Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J Virol 81:11817–11827CrossRefPubMedGoogle Scholar
  3. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM (2007) Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356:685–696CrossRefPubMedGoogle Scholar
  4. Bergmann M, García-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6206CrossRefPubMedGoogle Scholar
  5. Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL (2007) Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 81:1838–1847CrossRefPubMedGoogle Scholar
  6. Chen Z, Li Y, Krug RM (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J 18:2273–2283CrossRefPubMedGoogle Scholar
  7. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7:1306–1312CrossRefPubMedGoogle Scholar
  8. Dauber B, Heins G, Wolff T (2004) The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 78:1865–1872CrossRefPubMedGoogle Scholar
  9. Dauber B, Schneider J, Wolff T (2006) Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol 80:11667–11677CrossRefPubMedGoogle Scholar
  10. Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, García-Sastre A (2004) The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol 78:11574–11582CrossRefPubMedGoogle Scholar
  11. Efferson CL, Schickli J, Ko BK, Kawano K, Mouzi S, Palese P, García-Sastre A, Ioannides CG (2003) Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene. J Virol 77:7411–7424CrossRefPubMedGoogle Scholar
  12. Efferson CL, Tsuda N, Kawano K, Nistal-Villan E, Sellappan S, Yu D, Murray JL, García-Sastre A, Ioannides CG (2006) Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J Virol 80:383–394CrossRefPubMedGoogle Scholar
  13. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S (2007) Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81:3058–3067CrossRefPubMedGoogle Scholar
  14. Falcón AM, Fernández-Sesma A, Nakaya Y, Moran TM, Ortín J, García-Sastre A (2005) Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J Gen Virol 86:2817–2821CrossRefPubMedGoogle Scholar
  15. Ferko B, Stasakova J, Sereinig S, Romanova J, Katinger D, Niebler B, Katinger H, Egorov A (2001) Hyperattenuated recombinant influenza A virus nonstructural-protein- encoding vectors induce human immunodeficiency virus type 1 Nef- specific systemic and mucosal immune responses in mice. J Virol 75:8899–8908CrossRefPubMedGoogle Scholar
  16. Ferko B, Stasakova J, Romanova J, Kittel C, Sereinig S, Katinger H, Egorov A (2004) Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78:13037–13045CrossRefPubMedGoogle Scholar
  17. Ferko B, Kittel C, Romanova J, Sereinig S, Katinger H, Egorov A (2006) Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 80:11621–11627CrossRefPubMedGoogle Scholar
  18. Fernandez-Sesma A (2007) The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets 7:336–343CrossRefPubMedGoogle Scholar
  19. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, García-Sastre A, Moran TM (2006) Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80:6295–6304CrossRefPubMedGoogle Scholar
  20. Fortes P, Beloso A, Ortín J (1994) Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13:704–712PubMedGoogle Scholar
  21. García-Sastre A, Biron CA (2006) Type 1 interferons and the virus–host relationship: a lesson in détente. Science 312:879–882CrossRefPubMedGoogle Scholar
  22. García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330CrossRefPubMedGoogle Scholar
  23. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36:263–269CrossRefPubMedGoogle Scholar
  24. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103:14194–14199CrossRefPubMedGoogle Scholar
  25. Heikkinen LS, Kazlauskas A, Melen K, Wagner R, Ziegler T, Julkunen I, Saksela K (2008) Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling. J Biol Chem 283:5719–5727CrossRefPubMedGoogle Scholar
  26. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994–997CrossRefPubMedGoogle Scholar
  27. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA (2008) A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA 105:4381–4386CrossRefPubMedGoogle Scholar
  28. Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H (2008) A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82:1146–1154CrossRefPubMedGoogle Scholar
  29. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105CrossRefPubMedGoogle Scholar
  30. Kochs G, García-Sastre A, Martinez-Sobrido L (2007a) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021CrossRefGoogle Scholar
  31. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P (2007b) Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88:1403–1409CrossRefGoogle Scholar
  32. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M (2007) Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178:3368–3372PubMedGoogle Scholar
  33. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, García-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWt (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza herpes, and, Sindbis viruses. Proc Natl Acad Sci USA 104:1371–1376CrossRefPubMedGoogle Scholar
  34. Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, García-Sastre A, Ball LA, Palese P, Ding SW (2004) Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci USA 101:1350–13555CrossRefPubMedGoogle Scholar
  35. Li S, Min JY, Krug RM, Sen GC (2006a) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13–21CrossRefGoogle Scholar
  36. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z, Chen H (2006b) The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 80:11115–11123CrossRefGoogle Scholar
  37. Long JX, Peng DX, Liu YL, Wu YT, Liu XF (2008) Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes 36:471–478CrossRefPubMedGoogle Scholar
  38. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale M Jr (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335–345CrossRefPubMedGoogle Scholar
  39. López CB, García-Sastre A, Williams BRG, Moran TM (2003) Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187:1126–1136CrossRefPubMedGoogle Scholar
  40. Lu Y, Qian XY, Krug RM (1994) The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 8:1817–1828CrossRefPubMedGoogle Scholar
  41. Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222–228CrossRefPubMedGoogle Scholar
  42. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, García-Sastre A, Heins G, Wolff T (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal Kinase and AP-1 transcription factors. J Virol 76:11166–11171CrossRefPubMedGoogle Scholar
  43. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, García-Sastre A (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524CrossRefPubMedGoogle Scholar
  44. Min JY, Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci USA 103:7100–7105CrossRefPubMedGoogle Scholar
  45. Morley PS, Townsend HG, Bogdan JR, Haines DM (1999) Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J Am Vet Med Assoc 215:61–66PubMedGoogle Scholar
  46. Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422–428CrossRefPubMedGoogle Scholar
  47. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol Cell 1:991–1000CrossRefPubMedGoogle Scholar
  48. Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y, Rakestraw KM, Webster RG, Hoffmann E, Krauss S, Zheng J, Zhang Z, Naeve CW (2006) Large-scale sequence analysis of avian influenza isolates. Science 311:1576–1580CrossRefPubMedGoogle Scholar
  49. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9:930–938CrossRefPubMedGoogle Scholar
  50. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001CrossRefPubMedGoogle Scholar
  51. Qian XY, Alonso-Caplen F, Krug RM (1994) Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol 68:2433–2441PubMedGoogle Scholar
  52. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P (2005) Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431–8439CrossRefPubMedGoogle Scholar
  53. Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solorzano A, García-Sastre A (2006) Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol 80:11009–11018CrossRefPubMedGoogle Scholar
  54. Rintahaka J, Wiik D, Kovanen PE, Alenius H, Matikainen S (2008) Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J Immunol 180:1749–1757PubMedGoogle Scholar
  55. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778–809CrossRefPubMedGoogle Scholar
  56. Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM (2007) Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci USA 104:1853–1858CrossRefPubMedGoogle Scholar
  57. Sekellick MJ, Marcus PI (1985) Interferon induction by viruses. XIV. Development of interferon inducibility and its inhibition in chick embryo cells “aged” in vitro. J Interferon Res 5:651–667PubMedGoogle Scholar
  58. Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8:950–954CrossRefPubMedGoogle Scholar
  59. Sereinig S, Stukova M, Zabolotnyh N, Ferko B, Kittel C, Romanova J, Vinogradova T, Katinger H, Kiselev O, Egorov A (2006) Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge. Clin Vaccine Immunol 13:898–904CrossRefPubMedGoogle Scholar
  60. Smith EJ, Marié I, Prakash A, García-Sastre A, Levy DE (2001) IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by vaccinia virus E3L protein. J Biol Chem 276:8951–8957CrossRefPubMedGoogle Scholar
  61. Solórzano A, Webby RJ, Lager KM, Janke BH, García-Sastre A, Richt JA (2005) Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79:7535–7543CrossRefPubMedGoogle Scholar
  62. Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, Egorov A (2005) Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 86:185–195CrossRefPubMedGoogle Scholar
  63. Stukova MA, Sereinig S, Zabolotnyh NV, Ferko B, Kittel C, Romanova J, Vinogradova TI, Katinger H, Kiselev OI, Egorov A (2006) Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) 86:236–246CrossRefGoogle Scholar
  64. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A (2000a) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996CrossRefGoogle Scholar
  65. Talon J, Salvatore M, O’Neill RE, Nakaya Y, Zheng H, Muster T, García-Sastre A, Palese P (2000b) Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci USA 97:4309–4314CrossRefGoogle Scholar
  66. Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW (2001) Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J 33:637–643CrossRefPubMedGoogle Scholar
  67. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354:1343–1351CrossRefPubMedGoogle Scholar
  68. Twu KY, Kuo RL, Marklund J, Krug RM (2007) The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81:8112–8121CrossRefPubMedGoogle Scholar
  69. Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, García-Sastre A, Richt JA (2007) Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25:7999–8009CrossRefPubMedGoogle Scholar
  70. Wang W, Krug RM (1996) The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223:41–50CrossRefPubMedGoogle Scholar
  71. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, García-Sastre A (2000) Influenza A virus NS1 protein prevents the activation of NF-κB and induction of type I IFN. J Virol 74:11566–11573CrossRefPubMedGoogle Scholar
  72. Wang X, Basler CF, Williams BRG, Silverman RH, Palese P, García-Sastre A (2002) Functional replacement of the carboxy-terminal two thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–12962CrossRefPubMedGoogle Scholar
  73. Yuan W, Krug RM (2001) Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20:362–371CrossRefPubMedGoogle Scholar
  74. Zhirnov OP, Konakova TE, Wolff T, Klenk HD (2002) NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76:1617–1625CrossRefPubMedGoogle Scholar
  75. Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, Kawaoka Y, Chen H (2008) A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol 82:220–228CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Department of Diagnostic Medicine and Pathobiology, College of Veterinary MedicineKansas State UniversityManhattanUSA
  2. 2.Department of Microbiology; Department of Medicine, Division of Infectious Diseases; and Global Health and Emerging Pathogens InstituteMount Sinai School of MedicineNewYorkUSA

Personalised recommendations